
About Awinsa Life Sciences Private Limited
Data last updated:
Awinsa Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the medical transcription segment of the business process outsourcing sector. It was incorporated on 17 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC395289. Its GSTIN is 07AAQCA7970E1ZB (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It was formerly known as Awinsa Life Sceinces Private Limited. It is led by directors Mugdha Chopra and Sanjeev Kumar Miglani.
Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 13/9 First Floor Vasant Vihar New Delhi, Delhi, India – 110057.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.69 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹6.84 Cr (net margin 31.5%) and EBITDA of ₹9.61 Cr (EBITDA margin 44.3%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 40% over five years.
The company has about 38 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Awinsa Life Sciences.
For more details, the company can be reached via its website awinsals.com.
Company details
CIN history
Awinsa Life Sciences has one previous CIN (Corporate Identification Number): U74999HR2018PTC073606. The current CIN is U74999DL2018PTC395289, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999DL2018PTC395289 | Current |
| U74999HR2018PTC073606 | Previous |
Contact details
Awinsa Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is awinsals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressE – 13/9 First Floor Vasant Vihar New Delhi, Delhi, India – 110057
- IndustryBusiness Outsourcing, Medical Transcription
To see the full contact details of Awinsa Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Awinsa Life Sciences operates one associated brand: Awinsa Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as a CRO specializing in pharmacovigilance services. | awinsals.com |
Business activity
The main business activity of Awinsa Life Sciences is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Awinsa Life Sciences Private Limited, buy the company report.
Financials of Awinsa Life Sciences Private Limited
FY 2025 filings availableAwinsa Life Sciences Private Limited reported revenue of ₹21.69 Cr (up 33% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 33% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.61 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.84 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 44.3% | ||||
| Net Profit Margin | 31.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Awinsa Life Sciences Private Limited, buy the company report.
Board of directors of Awinsa Life Sciences Private Limited
Awinsa Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mugdha Chopra | Director | 17 Apr 2018 | 8 Years 7 Months | Current |
| Sanjeev Kumar Miglani | Director | 17 Apr 2018 | 8 Years 7 Months | Current |
Auditor
Awinsa Life Sciences Private Limited is audited by J GULATI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J GULATI & CO | FY 2022 | 037429N |
Shareholding
The shareholding of Awinsa Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Awinsa Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Awinsa Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Awinsa Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Awinsa Life Sciences Private Limited has a workforce of 38 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 38 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Awinsa Life Sciences Private Limited, buy the company report.
GST
Awinsa Life Sciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCA7970E1ZB | Delhi | Active | 21 Jun 2018 |
| 06AAQCA7970E1ZD | Haryana | Active | 27 Apr 2018 |
To see the full GST registrations and return filing status of Awinsa Life Sciences Private Limited, buy the company report.
Recent activity
Awinsa Life Sciences Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Mugdha Chopra was appointed as Director on 17 Apr 2018.
Frequently asked questions
Awinsa Life Sciences is an active private limited company based in Delhi, India. The company works in medical transcription, within the business outsourcing industry. It was incorporated on 17 April 2018 (8+ years old) and is registered under CIN U74999DL2018PTC395289.
Awinsa Life Sciences has 2 current directors:
- Mugdha Chopra - Director
- Sanjeev Kumar Miglani - Director
The latest financial statements of Awinsa Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Awinsa Life Sciences is 07AAQCA7970E1ZB, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAQCA7970E1ZD (Haryana).
The CIN (Corporate Identification Number) of Awinsa Life Sciences is U74999DL2018PTC395289. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Awinsa Life Sciences was incorporated on 17 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Mugdha Chopra was appointed as Director on 17 Apr 2018. Sanjeev Kumar Miglani was appointed as Director on 17 Apr 2018.
Awinsa Life Sciences can be reached through the website awinsals.com. Its registered office is in Delhi, India.
The registered office of Awinsa Life Sciences is at E – 139 First Floor Vasant Vihar New Delhi, Delhi, India – 110057.
Awinsa Life Sciences operates in the business outsourcing industry, in the medical transcription segment.

